Procter & Gamble Hygiene and Health Care Limited (NSE: PGHH.NS) Stock Competitors & Peer Comparison
See PGHH.NS's competitors and their performance on the NSE and across the wider stock market.
Peer Comparison Table: Household & Personal Products Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for PGHH.NS and its NSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| PGHH.NS | ₹8,136.50 | +0.11% | 262.6B | 34.81 | ₹232.38 | +3.15% |
| HINDUNILVR.NS | ₹2,021.00 | -0.44% | 4.8T | 42.68 | ₹47.43 | +2.03% |
| HINDUNILVR.BO | ₹2,030.00 | +0.15% | 4.7T | 43.77 | ₹46.24 | +2.03% |
| MARICO.NS | ₹833.00 | -1.55% | 1.1T | 57.61 | ₹14.71 | +0.47% |
| MARICO.BO | ₹833.95 | -1.48% | 1.1T | 57.62 | ₹14.68 | +0.47% |
| GODREJCP.NS | ₹922.80 | -0.66% | 950.9B | 45.57 | ₹20.39 | +2.15% |
| GODREJCP.BO | ₹927.00 | +0.01% | 939B | 45.33 | ₹20.30 | +2.15% |
| DABUR.BO | ₹391.00 | -1.91% | 702.9B | 37.05 | ₹10.66 | +2.09% |
| DABUR.NS | ₹392.20 | -1.57% | 700.8B | 37.06 | ₹10.66 | +2.09% |
| COLPAL.BO | ₹1,864.80 | -1.33% | 510.5B | 37.84 | ₹49.60 | +2.56% |
Stock Comparison
Hindustan Unilever Limited (NSE: HINDUNILVR.NS)
PGHH.NS vs HINDUNILVR.NS Comparison August 2026
Procter & Gamble Hygiene and Health Care Limited (NSE: PGHH.NS) plays a significant role within the Consumer Defensive sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGHH.NS stands at 262.6B. In comparison, HINDUNILVR.NS has a market cap of 4.8T. Regarding current trading prices, PGHH.NS is priced at ₹8,136.50 on the NSE, while HINDUNILVR.NS trades at ₹2,021.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGHH.NS currently has a P/E ratio of 34.81, whereas HINDUNILVR.NS's P/E ratio is 42.68. In terms of profitability, PGHH.NS's ROE is +1.08%, compared to HINDUNILVR.NS's ROE of +0.31%. Regarding short-term risk, PGHH.NS is less volatile compared to HINDUNILVR.NS. This indicates lower risk in terms of short-term price fluctuations for PGHH.NS.Check HINDUNILVR.NS's competition here
Hindustan Unilever Limited (BSE: HINDUNILVR.BO)
PGHH.NS vs HINDUNILVR.BO Comparison August 2026
Procter & Gamble Hygiene and Health Care Limited (NSE: PGHH.NS) plays a significant role within the Consumer Defensive sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGHH.NS stands at 262.6B. In comparison, HINDUNILVR.BO has a market cap of 4.7T. Regarding current trading prices, PGHH.NS is priced at ₹8,136.50 on the NSE, while HINDUNILVR.BO trades at ₹2,030.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGHH.NS currently has a P/E ratio of 34.81, whereas HINDUNILVR.BO's P/E ratio is 43.77. In terms of profitability, PGHH.NS's ROE is +1.08%, compared to HINDUNILVR.BO's ROE of +0.31%. Regarding short-term risk, PGHH.NS is less volatile compared to HINDUNILVR.BO. This indicates lower risk in terms of short-term price fluctuations for PGHH.NS.Check HINDUNILVR.BO's competition here
Marico Limited (NSE: MARICO.NS)
PGHH.NS vs MARICO.NS Comparison August 2026
Procter & Gamble Hygiene and Health Care Limited (NSE: PGHH.NS) plays a significant role within the Consumer Defensive sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGHH.NS stands at 262.6B. In comparison, MARICO.NS has a market cap of 1.1T. Regarding current trading prices, PGHH.NS is priced at ₹8,136.50 on the NSE, while MARICO.NS trades at ₹833.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGHH.NS currently has a P/E ratio of 34.81, whereas MARICO.NS's P/E ratio is 57.61. In terms of profitability, PGHH.NS's ROE is +1.08%, compared to MARICO.NS's ROE of +0.45%. Regarding short-term risk, PGHH.NS is less volatile compared to MARICO.NS. This indicates lower risk in terms of short-term price fluctuations for PGHH.NS.Check MARICO.NS's competition here
Marico Limited (BSE: MARICO.BO)
PGHH.NS vs MARICO.BO Comparison August 2026
Procter & Gamble Hygiene and Health Care Limited (NSE: PGHH.NS) plays a significant role within the Consumer Defensive sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGHH.NS stands at 262.6B. In comparison, MARICO.BO has a market cap of 1.1T. Regarding current trading prices, PGHH.NS is priced at ₹8,136.50 on the NSE, while MARICO.BO trades at ₹833.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGHH.NS currently has a P/E ratio of 34.81, whereas MARICO.BO's P/E ratio is 57.62. In terms of profitability, PGHH.NS's ROE is +1.08%, compared to MARICO.BO's ROE of +0.45%. Regarding short-term risk, PGHH.NS is less volatile compared to MARICO.BO. This indicates lower risk in terms of short-term price fluctuations for PGHH.NS.Check MARICO.BO's competition here
Godrej Consumer Products Limited (NSE: GODREJCP.NS)
PGHH.NS vs GODREJCP.NS Comparison August 2026
Procter & Gamble Hygiene and Health Care Limited (NSE: PGHH.NS) plays a significant role within the Consumer Defensive sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGHH.NS stands at 262.6B. In comparison, GODREJCP.NS has a market cap of 950.9B. Regarding current trading prices, PGHH.NS is priced at ₹8,136.50 on the NSE, while GODREJCP.NS trades at ₹922.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGHH.NS currently has a P/E ratio of 34.81, whereas GODREJCP.NS's P/E ratio is 45.57. In terms of profitability, PGHH.NS's ROE is +1.08%, compared to GODREJCP.NS's ROE of +0.15%. Regarding short-term risk, PGHH.NS is less volatile compared to GODREJCP.NS. This indicates lower risk in terms of short-term price fluctuations for PGHH.NS.Check GODREJCP.NS's competition here
Godrej Consumer Products Limited (BSE: GODREJCP.BO)
PGHH.NS vs GODREJCP.BO Comparison August 2026
Procter & Gamble Hygiene and Health Care Limited (NSE: PGHH.NS) plays a significant role within the Consumer Defensive sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGHH.NS stands at 262.6B. In comparison, GODREJCP.BO has a market cap of 939B. Regarding current trading prices, PGHH.NS is priced at ₹8,136.50 on the NSE, while GODREJCP.BO trades at ₹927.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGHH.NS currently has a P/E ratio of 34.81, whereas GODREJCP.BO's P/E ratio is 45.33. In terms of profitability, PGHH.NS's ROE is +1.08%, compared to GODREJCP.BO's ROE of +0.15%. Regarding short-term risk, PGHH.NS is more volatile compared to GODREJCP.BO. This indicates higher risk in terms of short-term price fluctuations for PGHH.NS.Check GODREJCP.BO's competition here
Dabur India Limited (BSE: DABUR.BO)
PGHH.NS vs DABUR.BO Comparison August 2026
Procter & Gamble Hygiene and Health Care Limited (NSE: PGHH.NS) plays a significant role within the Consumer Defensive sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGHH.NS stands at 262.6B. In comparison, DABUR.BO has a market cap of 702.9B. Regarding current trading prices, PGHH.NS is priced at ₹8,136.50 on the NSE, while DABUR.BO trades at ₹391.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGHH.NS currently has a P/E ratio of 34.81, whereas DABUR.BO's P/E ratio is 37.05. In terms of profitability, PGHH.NS's ROE is +1.08%, compared to DABUR.BO's ROE of +0.17%. Regarding short-term risk, PGHH.NS is less volatile compared to DABUR.BO. This indicates lower risk in terms of short-term price fluctuations for PGHH.NS.Check DABUR.BO's competition here
Dabur India Limited (NSE: DABUR.NS)
PGHH.NS vs DABUR.NS Comparison August 2026
Procter & Gamble Hygiene and Health Care Limited (NSE: PGHH.NS) plays a significant role within the Consumer Defensive sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGHH.NS stands at 262.6B. In comparison, DABUR.NS has a market cap of 700.8B. Regarding current trading prices, PGHH.NS is priced at ₹8,136.50 on the NSE, while DABUR.NS trades at ₹392.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGHH.NS currently has a P/E ratio of 34.81, whereas DABUR.NS's P/E ratio is 37.06. In terms of profitability, PGHH.NS's ROE is +1.08%, compared to DABUR.NS's ROE of +0.17%. Regarding short-term risk, PGHH.NS is less volatile compared to DABUR.NS. This indicates lower risk in terms of short-term price fluctuations for PGHH.NS.Check DABUR.NS's competition here
Colgate-Palmolive (India) Limited (BSE: COLPAL.BO)
PGHH.NS vs COLPAL.BO Comparison August 2026
Procter & Gamble Hygiene and Health Care Limited (NSE: PGHH.NS) plays a significant role within the Consumer Defensive sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGHH.NS stands at 262.6B. In comparison, COLPAL.BO has a market cap of 510.5B. Regarding current trading prices, PGHH.NS is priced at ₹8,136.50 on the NSE, while COLPAL.BO trades at ₹1,864.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGHH.NS currently has a P/E ratio of 34.81, whereas COLPAL.BO's P/E ratio is 37.84. In terms of profitability, PGHH.NS's ROE is +1.08%, compared to COLPAL.BO's ROE of +0.85%. Regarding short-term risk, PGHH.NS is more volatile compared to COLPAL.BO. This indicates higher risk in terms of short-term price fluctuations for PGHH.NS.Check COLPAL.BO's competition here
Colgate-Palmolive (India) Limited (NSE: COLPAL.NS)
PGHH.NS vs COLPAL.NS Comparison August 2026
Procter & Gamble Hygiene and Health Care Limited (NSE: PGHH.NS) plays a significant role within the Consumer Defensive sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGHH.NS stands at 262.6B. In comparison, COLPAL.NS has a market cap of 510.5B. Regarding current trading prices, PGHH.NS is priced at ₹8,136.50 on the NSE, while COLPAL.NS trades at ₹1,860.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGHH.NS currently has a P/E ratio of 34.81, whereas COLPAL.NS's P/E ratio is 37.60. In terms of profitability, PGHH.NS's ROE is +1.08%, compared to COLPAL.NS's ROE of +0.85%. Regarding short-term risk, PGHH.NS is less volatile compared to COLPAL.NS. This indicates lower risk in terms of short-term price fluctuations for PGHH.NS.Check COLPAL.NS's competition here
Cupid Limited (NSE: CUPID.NS)
PGHH.NS vs CUPID.NS Comparison August 2026
Procter & Gamble Hygiene and Health Care Limited (NSE: PGHH.NS) plays a significant role within the Consumer Defensive sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGHH.NS stands at 262.6B. In comparison, CUPID.NS has a market cap of 378.9B. Regarding current trading prices, PGHH.NS is priced at ₹8,136.50 on the NSE, while CUPID.NS trades at ₹283.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGHH.NS currently has a P/E ratio of 34.81, whereas CUPID.NS's P/E ratio is 352.20. In terms of profitability, PGHH.NS's ROE is +1.08%, compared to CUPID.NS's ROE of +0.33%. Regarding short-term risk, PGHH.NS is less volatile compared to CUPID.NS. This indicates lower risk in terms of short-term price fluctuations for PGHH.NS.Check CUPID.NS's competition here
Cupid Limited (BSE: CUPID.BO)
PGHH.NS vs CUPID.BO Comparison August 2026
Procter & Gamble Hygiene and Health Care Limited (NSE: PGHH.NS) plays a significant role within the Consumer Defensive sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGHH.NS stands at 262.6B. In comparison, CUPID.BO has a market cap of 378.4B. Regarding current trading prices, PGHH.NS is priced at ₹8,136.50 on the NSE, while CUPID.BO trades at ₹284.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGHH.NS currently has a P/E ratio of 34.81, whereas CUPID.BO's P/E ratio is 350.94. In terms of profitability, PGHH.NS's ROE is +1.08%, compared to CUPID.BO's ROE of +0.33%. Regarding short-term risk, PGHH.NS is less volatile compared to CUPID.BO. This indicates lower risk in terms of short-term price fluctuations for PGHH.NS.Check CUPID.BO's competition here
Procter & Gamble Hygiene and Health Care Limited (BSE: PGHH.BO)
PGHH.NS vs PGHH.BO Comparison August 2026
Procter & Gamble Hygiene and Health Care Limited (NSE: PGHH.NS) plays a significant role within the Consumer Defensive sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGHH.NS stands at 262.6B. In comparison, PGHH.BO has a market cap of 263B. Regarding current trading prices, PGHH.NS is priced at ₹8,136.50 on the NSE, while PGHH.BO trades at ₹8,126.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGHH.NS currently has a P/E ratio of 34.81, whereas PGHH.BO's P/E ratio is 33.18. In terms of profitability, PGHH.NS's ROE is +1.08%, compared to PGHH.BO's ROE of +1.08%. Regarding short-term risk, PGHH.NS is more volatile compared to PGHH.BO. This indicates higher risk in terms of short-term price fluctuations for PGHH.NS.Check PGHH.BO's competition here
Gillette India Limited (BSE: GILLETTE.BO)
PGHH.NS vs GILLETTE.BO Comparison August 2026
Procter & Gamble Hygiene and Health Care Limited (NSE: PGHH.NS) plays a significant role within the Consumer Defensive sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGHH.NS stands at 262.6B. In comparison, GILLETTE.BO has a market cap of 242.6B. Regarding current trading prices, PGHH.NS is priced at ₹8,136.50 on the NSE, while GILLETTE.BO trades at ₹7,401.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGHH.NS currently has a P/E ratio of 34.81, whereas GILLETTE.BO's P/E ratio is 36.95. In terms of profitability, PGHH.NS's ROE is +1.08%, compared to GILLETTE.BO's ROE of +0.63%. Regarding short-term risk, PGHH.NS is less volatile compared to GILLETTE.BO. This indicates lower risk in terms of short-term price fluctuations for PGHH.NS.Check GILLETTE.BO's competition here
Gillette India Limited (NSE: GILLETTE.NS)
PGHH.NS vs GILLETTE.NS Comparison August 2026
Procter & Gamble Hygiene and Health Care Limited (NSE: PGHH.NS) plays a significant role within the Consumer Defensive sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGHH.NS stands at 262.6B. In comparison, GILLETTE.NS has a market cap of 242.4B. Regarding current trading prices, PGHH.NS is priced at ₹8,136.50 on the NSE, while GILLETTE.NS trades at ₹7,403.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGHH.NS currently has a P/E ratio of 34.81, whereas GILLETTE.NS's P/E ratio is 36.88. In terms of profitability, PGHH.NS's ROE is +1.08%, compared to GILLETTE.NS's ROE of +0.63%. Regarding short-term risk, PGHH.NS is less volatile compared to GILLETTE.NS. This indicates lower risk in terms of short-term price fluctuations for PGHH.NS.Check GILLETTE.NS's competition here
Emami Limited (BSE: EMAMILTD.BO)
PGHH.NS vs EMAMILTD.BO Comparison August 2026
Procter & Gamble Hygiene and Health Care Limited (NSE: PGHH.NS) plays a significant role within the Consumer Defensive sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGHH.NS stands at 262.6B. In comparison, EMAMILTD.BO has a market cap of 175.9B. Regarding current trading prices, PGHH.NS is priced at ₹8,136.50 on the NSE, while EMAMILTD.BO trades at ₹401.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGHH.NS currently has a P/E ratio of 34.81, whereas EMAMILTD.BO's P/E ratio is 22.90. In terms of profitability, PGHH.NS's ROE is +1.08%, compared to EMAMILTD.BO's ROE of +0.26%. Regarding short-term risk, PGHH.NS is less volatile compared to EMAMILTD.BO. This indicates lower risk in terms of short-term price fluctuations for PGHH.NS.Check EMAMILTD.BO's competition here
Emami Limited (NSE: EMAMILTD.NS)
PGHH.NS vs EMAMILTD.NS Comparison August 2026
Procter & Gamble Hygiene and Health Care Limited (NSE: PGHH.NS) plays a significant role within the Consumer Defensive sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGHH.NS stands at 262.6B. In comparison, EMAMILTD.NS has a market cap of 175.8B. Regarding current trading prices, PGHH.NS is priced at ₹8,136.50 on the NSE, while EMAMILTD.NS trades at ₹401.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGHH.NS currently has a P/E ratio of 34.81, whereas EMAMILTD.NS's P/E ratio is 22.85. In terms of profitability, PGHH.NS's ROE is +1.08%, compared to EMAMILTD.NS's ROE of +0.26%. Regarding short-term risk, PGHH.NS is less volatile compared to EMAMILTD.NS. This indicates lower risk in terms of short-term price fluctuations for PGHH.NS.Check EMAMILTD.NS's competition here
Honasa Consumer Limited (NSE: HONASA.NS)
PGHH.NS vs HONASA.NS Comparison August 2026
Procter & Gamble Hygiene and Health Care Limited (NSE: PGHH.NS) plays a significant role within the Consumer Defensive sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGHH.NS stands at 262.6B. In comparison, HONASA.NS has a market cap of 158.3B. Regarding current trading prices, PGHH.NS is priced at ₹8,136.50 on the NSE, while HONASA.NS trades at ₹475.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGHH.NS currently has a P/E ratio of 34.81, whereas HONASA.NS's P/E ratio is 61.93. In terms of profitability, PGHH.NS's ROE is +1.08%, compared to HONASA.NS's ROE of +0.20%. Regarding short-term risk, PGHH.NS is less volatile compared to HONASA.NS. This indicates lower risk in terms of short-term price fluctuations for PGHH.NS.Check HONASA.NS's competition here
Honasa Consumer Limited (BSE: HONASA.BO)
PGHH.NS vs HONASA.BO Comparison August 2026
Procter & Gamble Hygiene and Health Care Limited (NSE: PGHH.NS) plays a significant role within the Consumer Defensive sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGHH.NS stands at 262.6B. In comparison, HONASA.BO has a market cap of 157.6B. Regarding current trading prices, PGHH.NS is priced at ₹8,136.50 on the NSE, while HONASA.BO trades at ₹475.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGHH.NS currently has a P/E ratio of 34.81, whereas HONASA.BO's P/E ratio is 62.24. In terms of profitability, PGHH.NS's ROE is +1.08%, compared to HONASA.BO's ROE of +0.20%. Regarding short-term risk, PGHH.NS is less volatile compared to HONASA.BO. This indicates lower risk in terms of short-term price fluctuations for PGHH.NS.Check HONASA.BO's competition here
Jyothy Labs Limited (NSE: JYOTHYLAB.NS)
PGHH.NS vs JYOTHYLAB.NS Comparison August 2026
Procter & Gamble Hygiene and Health Care Limited (NSE: PGHH.NS) plays a significant role within the Consumer Defensive sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGHH.NS stands at 262.6B. In comparison, JYOTHYLAB.NS has a market cap of 78.1B. Regarding current trading prices, PGHH.NS is priced at ₹8,136.50 on the NSE, while JYOTHYLAB.NS trades at ₹211.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGHH.NS currently has a P/E ratio of 34.81, whereas JYOTHYLAB.NS's P/E ratio is 27.51. In terms of profitability, PGHH.NS's ROE is +1.08%, compared to JYOTHYLAB.NS's ROE of +0.17%. Regarding short-term risk, PGHH.NS is less volatile compared to JYOTHYLAB.NS. This indicates lower risk in terms of short-term price fluctuations for PGHH.NS.Check JYOTHYLAB.NS's competition here
Jyothy Labs Limited (BSE: JYOTHYLAB.BO)
PGHH.NS vs JYOTHYLAB.BO Comparison August 2026
Procter & Gamble Hygiene and Health Care Limited (NSE: PGHH.NS) plays a significant role within the Consumer Defensive sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGHH.NS stands at 262.6B. In comparison, JYOTHYLAB.BO has a market cap of 78B. Regarding current trading prices, PGHH.NS is priced at ₹8,136.50 on the NSE, while JYOTHYLAB.BO trades at ₹211.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGHH.NS currently has a P/E ratio of 34.81, whereas JYOTHYLAB.BO's P/E ratio is 27.52. In terms of profitability, PGHH.NS's ROE is +1.08%, compared to JYOTHYLAB.BO's ROE of +0.17%. Regarding short-term risk, PGHH.NS is less volatile compared to JYOTHYLAB.BO. This indicates lower risk in terms of short-term price fluctuations for PGHH.NS.Check JYOTHYLAB.BO's competition here
Bajaj Consumer Care Limited (NSE: BAJAJCON.NS)
PGHH.NS vs BAJAJCON.NS Comparison August 2026
Procter & Gamble Hygiene and Health Care Limited (NSE: PGHH.NS) plays a significant role within the Consumer Defensive sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGHH.NS stands at 262.6B. In comparison, BAJAJCON.NS has a market cap of 59.7B. Regarding current trading prices, PGHH.NS is priced at ₹8,136.50 on the NSE, while BAJAJCON.NS trades at ₹463.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGHH.NS currently has a P/E ratio of 34.81, whereas BAJAJCON.NS's P/E ratio is 27.76. In terms of profitability, PGHH.NS's ROE is +1.08%, compared to BAJAJCON.NS's ROE of +0.32%. Regarding short-term risk, PGHH.NS is less volatile compared to BAJAJCON.NS. This indicates lower risk in terms of short-term price fluctuations for PGHH.NS.Check BAJAJCON.NS's competition here
Bajaj Consumer Care Limited (BSE: BAJAJCON.BO)
PGHH.NS vs BAJAJCON.BO Comparison August 2026
Procter & Gamble Hygiene and Health Care Limited (NSE: PGHH.NS) plays a significant role within the Consumer Defensive sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGHH.NS stands at 262.6B. In comparison, BAJAJCON.BO has a market cap of 59.6B. Regarding current trading prices, PGHH.NS is priced at ₹8,136.50 on the NSE, while BAJAJCON.BO trades at ₹464.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGHH.NS currently has a P/E ratio of 34.81, whereas BAJAJCON.BO's P/E ratio is 27.77. In terms of profitability, PGHH.NS's ROE is +1.08%, compared to BAJAJCON.BO's ROE of +0.32%. Regarding short-term risk, PGHH.NS is less volatile compared to BAJAJCON.BO. This indicates lower risk in terms of short-term price fluctuations for PGHH.NS.Check BAJAJCON.BO's competition here
All Time Plastics Ltd. (NSE: ALLTIME.NS)
PGHH.NS vs ALLTIME.NS Comparison August 2026
Procter & Gamble Hygiene and Health Care Limited (NSE: PGHH.NS) plays a significant role within the Consumer Defensive sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGHH.NS stands at 262.6B. In comparison, ALLTIME.NS has a market cap of 13.4B. Regarding current trading prices, PGHH.NS is priced at ₹8,136.50 on the NSE, while ALLTIME.NS trades at ₹206.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGHH.NS currently has a P/E ratio of 34.81, whereas ALLTIME.NS's P/E ratio is 35.34. In terms of profitability, PGHH.NS's ROE is +1.08%, compared to ALLTIME.NS's ROE of +0.07%. Regarding short-term risk, PGHH.NS is less volatile compared to ALLTIME.NS. This indicates lower risk in terms of short-term price fluctuations for PGHH.NS.Check ALLTIME.NS's competition here
Kaya Limited (NSE: KAYA.NS)
PGHH.NS vs KAYA.NS Comparison August 2026
Procter & Gamble Hygiene and Health Care Limited (NSE: PGHH.NS) plays a significant role within the Consumer Defensive sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGHH.NS stands at 262.6B. In comparison, KAYA.NS has a market cap of 5.3B. Regarding current trading prices, PGHH.NS is priced at ₹8,136.50 on the NSE, while KAYA.NS trades at ₹351.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGHH.NS currently has a P/E ratio of 34.81, whereas KAYA.NS's P/E ratio is -5.40. In terms of profitability, PGHH.NS's ROE is +1.08%, compared to KAYA.NS's ROE of +0.79%. Regarding short-term risk, PGHH.NS is less volatile compared to KAYA.NS. This indicates lower risk in terms of short-term price fluctuations for PGHH.NS.Check KAYA.NS's competition here
Kaya Limited (BSE: KAYA.BO)
PGHH.NS vs KAYA.BO Comparison August 2026
Procter & Gamble Hygiene and Health Care Limited (NSE: PGHH.NS) plays a significant role within the Consumer Defensive sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGHH.NS stands at 262.6B. In comparison, KAYA.BO has a market cap of 5.3B. Regarding current trading prices, PGHH.NS is priced at ₹8,136.50 on the NSE, while KAYA.BO trades at ₹350.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGHH.NS currently has a P/E ratio of 34.81, whereas KAYA.BO's P/E ratio is -5.43. In terms of profitability, PGHH.NS's ROE is +1.08%, compared to KAYA.BO's ROE of +0.79%. Regarding short-term risk, PGHH.NS is less volatile compared to KAYA.BO. This indicates lower risk in terms of short-term price fluctuations for PGHH.NS.Check KAYA.BO's competition here
Ador Multiproducts Limited (BSE: ADORMUL.BO)
PGHH.NS vs ADORMUL.BO Comparison August 2026
Procter & Gamble Hygiene and Health Care Limited (NSE: PGHH.NS) plays a significant role within the Consumer Defensive sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGHH.NS stands at 262.6B. In comparison, ADORMUL.BO has a market cap of 1.3B. Regarding current trading prices, PGHH.NS is priced at ₹8,136.50 on the NSE, while ADORMUL.BO trades at ₹135.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGHH.NS currently has a P/E ratio of 34.81, whereas ADORMUL.BO's P/E ratio is -29.80. In terms of profitability, PGHH.NS's ROE is +1.08%, compared to ADORMUL.BO's ROE of -0.26%. Regarding short-term risk, PGHH.NS is less volatile compared to ADORMUL.BO. This indicates lower risk in terms of short-term price fluctuations for PGHH.NS.Check ADORMUL.BO's competition here
Pee Cee Cosma Sope Limited (BSE: PCCOSMA.BO)
PGHH.NS vs PCCOSMA.BO Comparison August 2026
Procter & Gamble Hygiene and Health Care Limited (NSE: PGHH.NS) plays a significant role within the Consumer Defensive sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGHH.NS stands at 262.6B. In comparison, PCCOSMA.BO has a market cap of 1.1B. Regarding current trading prices, PGHH.NS is priced at ₹8,136.50 on the NSE, while PCCOSMA.BO trades at ₹439.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGHH.NS currently has a P/E ratio of 34.81, whereas PCCOSMA.BO's P/E ratio is 17.07. In terms of profitability, PGHH.NS's ROE is +1.08%, compared to PCCOSMA.BO's ROE of +0.16%. Regarding short-term risk, PGHH.NS is less volatile compared to PCCOSMA.BO. This indicates lower risk in terms of short-term price fluctuations for PGHH.NS.Check PCCOSMA.BO's competition here
Aayush Wellness Ltd (BSE: AAYUSH.BO)
PGHH.NS vs AAYUSH.BO Comparison August 2026
Procter & Gamble Hygiene and Health Care Limited (NSE: PGHH.NS) plays a significant role within the Consumer Defensive sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGHH.NS stands at 262.6B. In comparison, AAYUSH.BO has a market cap of 1.1B. Regarding current trading prices, PGHH.NS is priced at ₹8,136.50 on the NSE, while AAYUSH.BO trades at ₹21.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGHH.NS currently has a P/E ratio of 34.81, whereas AAYUSH.BO's P/E ratio is 26.00. In terms of profitability, PGHH.NS's ROE is +1.08%, compared to AAYUSH.BO's ROE of +0.41%. Regarding short-term risk, PGHH.NS is less volatile compared to AAYUSH.BO. This indicates lower risk in terms of short-term price fluctuations for PGHH.NS.Check AAYUSH.BO's competition here
Lykis Limited (BSE: LYKISLTD.BO)
PGHH.NS vs LYKISLTD.BO Comparison August 2026
Procter & Gamble Hygiene and Health Care Limited (NSE: PGHH.NS) plays a significant role within the Consumer Defensive sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGHH.NS stands at 262.6B. In comparison, LYKISLTD.BO has a market cap of 1B. Regarding current trading prices, PGHH.NS is priced at ₹8,136.50 on the NSE, while LYKISLTD.BO trades at ₹55.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGHH.NS currently has a P/E ratio of 34.81, whereas LYKISLTD.BO's P/E ratio is 16.17. In terms of profitability, PGHH.NS's ROE is +1.08%, compared to LYKISLTD.BO's ROE of +0.29%. Regarding short-term risk, PGHH.NS is less volatile compared to LYKISLTD.BO. This indicates lower risk in terms of short-term price fluctuations for PGHH.NS.Check LYKISLTD.BO's competition here
JHS Svendgaard Laboratories Limited (BSE: JHS.BO)
PGHH.NS vs JHS.BO Comparison August 2026
Procter & Gamble Hygiene and Health Care Limited (NSE: PGHH.NS) plays a significant role within the Consumer Defensive sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGHH.NS stands at 262.6B. In comparison, JHS.BO has a market cap of 782M. Regarding current trading prices, PGHH.NS is priced at ₹8,136.50 on the NSE, while JHS.BO trades at ₹9.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGHH.NS currently has a P/E ratio of 34.81, whereas JHS.BO's P/E ratio is -39.30. In terms of profitability, PGHH.NS's ROE is +1.08%, compared to JHS.BO's ROE of -0.01%. Regarding short-term risk, PGHH.NS is less volatile compared to JHS.BO. This indicates lower risk in terms of short-term price fluctuations for PGHH.NS.Check JHS.BO's competition here
JHS Svendgaard Laboratories Limited (NSE: JHS.NS)
PGHH.NS vs JHS.NS Comparison August 2026
Procter & Gamble Hygiene and Health Care Limited (NSE: PGHH.NS) plays a significant role within the Consumer Defensive sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGHH.NS stands at 262.6B. In comparison, JHS.NS has a market cap of 777M. Regarding current trading prices, PGHH.NS is priced at ₹8,136.50 on the NSE, while JHS.NS trades at ₹9.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGHH.NS currently has a P/E ratio of 34.81, whereas JHS.NS's P/E ratio is -38.65. In terms of profitability, PGHH.NS's ROE is +1.08%, compared to JHS.NS's ROE of -0.01%. Regarding short-term risk, PGHH.NS is less volatile compared to JHS.NS. This indicates lower risk in terms of short-term price fluctuations for PGHH.NS.Check JHS.NS's competition here
Ambica Agarbathies Aroma & Industries Limited (NSE: AMBICAAGAR.NS)
PGHH.NS vs AMBICAAGAR.NS Comparison August 2026
Procter & Gamble Hygiene and Health Care Limited (NSE: PGHH.NS) plays a significant role within the Consumer Defensive sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGHH.NS stands at 262.6B. In comparison, AMBICAAGAR.NS has a market cap of 436.6M. Regarding current trading prices, PGHH.NS is priced at ₹8,136.50 on the NSE, while AMBICAAGAR.NS trades at ₹24.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGHH.NS currently has a P/E ratio of 34.81, whereas AMBICAAGAR.NS's P/E ratio is 15.13. In terms of profitability, PGHH.NS's ROE is +1.08%, compared to AMBICAAGAR.NS's ROE of +0.03%. Regarding short-term risk, PGHH.NS is less volatile compared to AMBICAAGAR.NS. This indicates lower risk in terms of short-term price fluctuations for PGHH.NS.Check AMBICAAGAR.NS's competition here
Ambica Agarbathies Aroma & Industries Limited (BSE: AMBICAAGAR.BO)
PGHH.NS vs AMBICAAGAR.BO Comparison August 2026
Procter & Gamble Hygiene and Health Care Limited (NSE: PGHH.NS) plays a significant role within the Consumer Defensive sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGHH.NS stands at 262.6B. In comparison, AMBICAAGAR.BO has a market cap of 422.9M. Regarding current trading prices, PGHH.NS is priced at ₹8,136.50 on the NSE, while AMBICAAGAR.BO trades at ₹24.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGHH.NS currently has a P/E ratio of 34.81, whereas AMBICAAGAR.BO's P/E ratio is 14.71. In terms of profitability, PGHH.NS's ROE is +1.08%, compared to AMBICAAGAR.BO's ROE of +0.03%. Regarding short-term risk, PGHH.NS is less volatile compared to AMBICAAGAR.BO. This indicates lower risk in terms of short-term price fluctuations for PGHH.NS.Check AMBICAAGAR.BO's competition here
N.K Industries Limited (BSE: NKIND.BO)
PGHH.NS vs NKIND.BO Comparison August 2026
Procter & Gamble Hygiene and Health Care Limited (NSE: PGHH.NS) plays a significant role within the Consumer Defensive sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGHH.NS stands at 262.6B. In comparison, NKIND.BO has a market cap of 378.5M. Regarding current trading prices, PGHH.NS is priced at ₹8,136.50 on the NSE, while NKIND.BO trades at ₹61.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGHH.NS currently has a P/E ratio of 34.81, whereas NKIND.BO's P/E ratio is -89.20. In terms of profitability, PGHH.NS's ROE is +1.08%, compared to NKIND.BO's ROE of +0.01%. Regarding short-term risk, PGHH.NS is less volatile compared to NKIND.BO. This indicates lower risk in terms of short-term price fluctuations for PGHH.NS.Check NKIND.BO's competition here
N.K Industries Limited (NSE: NKIND.NS)
PGHH.NS vs NKIND.NS Comparison August 2026
Procter & Gamble Hygiene and Health Care Limited (NSE: PGHH.NS) plays a significant role within the Consumer Defensive sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGHH.NS stands at 262.6B. In comparison, NKIND.NS has a market cap of 354.9M. Regarding current trading prices, PGHH.NS is priced at ₹8,136.50 on the NSE, while NKIND.NS trades at ₹59.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGHH.NS currently has a P/E ratio of 34.81, whereas NKIND.NS's P/E ratio is -13.96. In terms of profitability, PGHH.NS's ROE is +1.08%, compared to NKIND.NS's ROE of +0.01%. Regarding short-term risk, PGHH.NS is less volatile compared to NKIND.NS. This indicates lower risk in terms of short-term price fluctuations for PGHH.NS.Check NKIND.NS's competition here
Nuway Organic Naturals India Limited (BSE: NUWAY.BO)
PGHH.NS vs NUWAY.BO Comparison August 2026
Procter & Gamble Hygiene and Health Care Limited (NSE: PGHH.NS) plays a significant role within the Consumer Defensive sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGHH.NS stands at 262.6B. In comparison, NUWAY.BO has a market cap of 354.6M. Regarding current trading prices, PGHH.NS is priced at ₹8,136.50 on the NSE, while NUWAY.BO trades at ₹37.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGHH.NS currently has a P/E ratio of 34.81, whereas NUWAY.BO's P/E ratio is 14.40. In terms of profitability, PGHH.NS's ROE is +1.08%, compared to NUWAY.BO's ROE of N/A. Regarding short-term risk, PGHH.NS is more volatile compared to NUWAY.BO. This indicates higher risk in terms of short-term price fluctuations for PGHH.NS.Check NUWAY.BO's competition here
Hipolin Limited (BSE: HIPOLIN.BO)
PGHH.NS vs HIPOLIN.BO Comparison August 2026
Procter & Gamble Hygiene and Health Care Limited (NSE: PGHH.NS) plays a significant role within the Consumer Defensive sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGHH.NS stands at 262.6B. In comparison, HIPOLIN.BO has a market cap of 322.7M. Regarding current trading prices, PGHH.NS is priced at ₹8,136.50 on the NSE, while HIPOLIN.BO trades at ₹104.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGHH.NS currently has a P/E ratio of 34.81, whereas HIPOLIN.BO's P/E ratio is -58.07. In terms of profitability, PGHH.NS's ROE is +1.08%, compared to HIPOLIN.BO's ROE of +0.01%. Regarding short-term risk, PGHH.NS is less volatile compared to HIPOLIN.BO. This indicates lower risk in terms of short-term price fluctuations for PGHH.NS.Check HIPOLIN.BO's competition here
PAOS Industries Limited (BSE: PAOS.BO)
PGHH.NS vs PAOS.BO Comparison August 2026
Procter & Gamble Hygiene and Health Care Limited (NSE: PGHH.NS) plays a significant role within the Consumer Defensive sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGHH.NS stands at 262.6B. In comparison, PAOS.BO has a market cap of 245M. Regarding current trading prices, PGHH.NS is priced at ₹8,136.50 on the NSE, while PAOS.BO trades at ₹38.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGHH.NS currently has a P/E ratio of 34.81, whereas PAOS.BO's P/E ratio is -11.60. In terms of profitability, PGHH.NS's ROE is +1.08%, compared to PAOS.BO's ROE of +0.09%. Regarding short-term risk, PGHH.NS is less volatile compared to PAOS.BO. This indicates lower risk in terms of short-term price fluctuations for PGHH.NS.Check PAOS.BO's competition here
Paramount Cosmetics (India) Limited (BSE: PARMCOS-B.BO)
PGHH.NS vs PARMCOS-B.BO Comparison August 2026
Procter & Gamble Hygiene and Health Care Limited (NSE: PGHH.NS) plays a significant role within the Consumer Defensive sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGHH.NS stands at 262.6B. In comparison, PARMCOS-B.BO has a market cap of 184.5M. Regarding current trading prices, PGHH.NS is priced at ₹8,136.50 on the NSE, while PARMCOS-B.BO trades at ₹38.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGHH.NS currently has a P/E ratio of 34.81, whereas PARMCOS-B.BO's P/E ratio is 612.90. In terms of profitability, PGHH.NS's ROE is +1.08%, compared to PARMCOS-B.BO's ROE of +0.01%. Regarding short-term risk, PGHH.NS is more volatile compared to PARMCOS-B.BO. This indicates higher risk in terms of short-term price fluctuations for PGHH.NS.Check PARMCOS-B.BO's competition here
Add-Shop E-Retail Limited (BSE: ASRL.BO)
PGHH.NS vs ASRL.BO Comparison August 2026
Procter & Gamble Hygiene and Health Care Limited (NSE: PGHH.NS) plays a significant role within the Consumer Defensive sector. Its performance on the NSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PGHH.NS stands at 262.6B. In comparison, ASRL.BO has a market cap of 167.9M. Regarding current trading prices, PGHH.NS is priced at ₹8,136.50 on the NSE, while ASRL.BO trades at ₹6.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PGHH.NS currently has a P/E ratio of 34.81, whereas ASRL.BO's P/E ratio is 5.33. In terms of profitability, PGHH.NS's ROE is +1.08%, compared to ASRL.BO's ROE of +0.01%. Regarding short-term risk, PGHH.NS is less volatile compared to ASRL.BO. This indicates lower risk in terms of short-term price fluctuations for PGHH.NS.Check ASRL.BO's competition here